No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
251 |
6. Filter based on genotype QC (FinnGen only) |
251 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Lung transplantation
based on the number of shared cases.
Similar with more cases:
- Factors influencing health status and contact with health services
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 635 | 264 | 371 |
| Only index persons | 569 | 239 | 330 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | - | 54.38 | 58.17 |
| Only index persons | 56.75 | 54.62 | 58.30 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 251 | 103 | 148 |
| Unadjusted period prevalence (%) | 0.05 | 0.04 | 0.07 |
| Median age at first event (years) | 57.10 | 54.62 | 58.83 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 223
- Matched controls
- 2229
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z94.2
ICD-10 Finland
Lung transplant status
+∞
319.6
222
*
127
Kela drug reimbursment
Transplant complication
890.6
238.3
199
20
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
7062.7
214.2
171
*
L04AA06
ATC
mycophenolic acid; systemic
456.9
210.9
186
24
GDG10
NOMESCO Finland
Bilateral transplantation of lung
+∞
198.9
160
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
116.8
157.8
167
55
UGC12
NOMESCO Finland
Flexible bronchoscopy
86.9
148.9
169
77
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
104.9
138.7
147
40
TGC00
NOMESCO Finland
Bronchial lavation
133.6
137.0
139
27
L04AD01
ATC
ciclosporin; systemic
165.7
135.9
134
20
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
1150.6
130.5
115
*
GD1AD
NOMESCO Finland
Thorax CT examination
87.1
128.1
140
42
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
44.3
122.5
183
208
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
202.3
120.8
117
12
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
56.2
117.2
142
67
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
49.7
115.1
145
80
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
+∞
112.2
98
*
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
385.8
111.9
104
5
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
41.2
111.4
197
345
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
245.1
109.6
105
8
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
60.8
109.2
128
48
R4110
NOMESCO Finland
Physiotherapy
39.2
106.3
199
389
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
46.9
103.0
129
63
GD1AA
NOMESCO Finland
Thorax X-ray examination
56.2
94.2
213
612
C08CA02
ATC
felodipine; oral
36.6
93.8
126
76
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
61.9
91.8
106
32
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
39.2
91.2
119
63
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
51.0
87.2
105
38
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
21.2
84.5
148
189
XX4BW
NOMESCO Finland
NA
1160.3
84.3
77
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
19.8
81.2
146
194
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
27.6
79.5
116
84
WX872
NOMESCO Finland
Intensive care
35.7
79.3
105
54
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
17.7
78.4
174
371
ZX108
NOMESCO Finland
Inhalation
179.2
73.0
73
6
WX302
NOMESCO Finland
Thoracal epidural anesthesy
34.1
72.8
97
49
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
93.1
69.8
75
12
J18.9
ICD-10 Finland
Pneumonia, unspecified
14.6
67.4
140
231
Z3226
NOMESCO Finland
Physiotherapist
13.8
66.2
144
259
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
29.9
65.9
91
50
Z2446
NOMESCO Finland
Social worker
21.8
65.9
103
84
WX404
NOMESCO Finland
Intravenous generell anesthesy
13.1
64.6
149
297
H02AB06
ATC
prednisolone; systemic
17.1
63.5
198
706
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
277.7
62.6
61
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
18.7
60.8
101
94
C03CA01
ATC
furosemide; systemic
12.3
59.8
135
247
WX408
NOMESCO Finland
General anesthesy, balanced
11.3
58.9
160
409
C10AA03
ATC
pravastatin; oral
23.5
58.9
88
60
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
11.9
58.1
133
246
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
20.7
56.8
89
69
ZXE40
NOMESCO Finland
More than seven and less than nine hours
45.9
55.8
68
21
5AB14
NOMESCO Finland
NA
+∞
55.6
51
*
Z2221
NOMESCO Finland
Medical doctor
10.4
55.4
152
380
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
41.0
55.2
69
24
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
145.0
53.6
55
5
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
16.7
51.9
89
85
L04AX01
ATC
azathioprine; systemic
25.9
51.2
73
41
ZX120
NOMESCO Finland
Intravenous
14.3
50.9
95
110
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
19.8
50.1
79
60
A07AA02
ATC
nystatin; oral
20.1
49.8
78
58
J96.1
ICD-10 Finland
Chronic respiratory failure
65.8
48.5
55
11
GD1RA
NOMESCO Finland
Dynamic X-ray examination of respiratory organs with convetional X-ray picture
555.1
47.1
45
*
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
197.1
46.8
47
*
ZXA10
NOMESCO Finland
Bilateral
9.5
46.2
115
224
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
18.2
45.0
73
58
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
14.9
44.3
79
79
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
23.0
44.2
65
39
ZXE30
NOMESCO Finland
More than five and less than seven hours
16.7
44.1
74
64
ZXE00
NOMESCO Finland
One hour or less
7.9
43.4
167
610
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
75.8
43.2
48
8
ZXD10
NOMESCO Finland
Scheduled procedure
7.7
43.2
162
569
ZXE10
NOMESCO Finland
More than one and less than three hours
7.4
41.9
156
533
J01MA14
ATC
moxifloxacin; systemic
12.3
39.9
78
93
284
Kela drug reimbursment
Nintedanib and pirfenidone
435.8
38.2
37
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
7.4
37.9
114
277
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
83.1
37.4
41
6
C07AB07
ATC
bisoprolol; oral
6.4
36.6
157
600
C10AA01
ATC
simvastatin; oral
6.3
36.3
151
553
2AX04
NOMESCO Finland
NA
407.6
36.0
35
*
XG410
NOMESCO Finland
Flow-volume spirometry
19.3
36.0
56
38
JN4BD
NOMESCO Finland
Extensive body CT
9.2
35.2
82
132
RS123
NOMESCO Finland
NA
403.3
34.9
34
*
5BA08
NOMESCO Finland
NA
199.3
33.7
34
*
XG466
NOMESCO Finland
Sleep oxymetry
22.9
33.7
49
27
C09AA05
ATC
ramipril; oral
6.5
33.5
109
284
R4190
NOMESCO Finland
Nutritional therapy
19.0
33.4
52
35
L04AX05
ATC
pirfenidone; oral
+∞
33.1
31
*
R03BB04
ATC
tiotropium bromide; inhalant
12.0
33.1
64
72
Z3231
NOMESCO Finland
Registered nurse
5.9
32.9
125
393
TPH04
NOMESCO Finland
Cathetrisation of vein
6.7
32.6
102
250
A02BA03
ATC
famotidine; systemic
24.8
32.5
46
23
R03AC02
ATC
salbutamol; inhalant
6.0
32.2
172
798
3A006
NOMESCO Finland
NA
+∞
32.0
30
*
ZXD05
NOMESCO Finland
Urgent procedure
5.7
31.8
126
412
TK800
NOMESCO Finland
Hemodialysis
21.9
31.3
46
26
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
17.5
31.2
50
36
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
10.7
30.7
63
79
Z94.0
ICD-10 Finland
Kidney transplant status
36.0
30.6
39
13
WX402
NOMESCO Finland
General anaesthesia
6.5
30.4
94
223
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
28.3
29.5
40
17
356
Kela drug reimbursment
Nintedanib and pirfenidone
332.8
29.5
29
*
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
12.6
29.0
54
55
R50.9
ICD-10 Finland
Fever, unspecified
7.6
29.0
76
142
TPH07
NOMESCO Finland
Cathetrisation of artery
8.6
28.7
68
108
WX892
NOMESCO Finland
Monitored bed care
10.5
28.6
59
74
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
10.3
28.3
59
75
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
6.5
28.0
85
193
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
5.3
27.8
170
844
ZX197
NOMESCO Finland
NA
+∞
27.7
26
*
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
305.7
27.3
27
*
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
22.2
26.8
39
21
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
28.3
26.7
36
15
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
46.3
26.6
32
8
WX740
NOMESCO Finland
Nitrogen oxide therapy
+∞
26.6
25
*
XJC10
NOMESCO Finland
Oesophageal pH monitoring
106.2
26.3
28
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
22.6
26.3
38
20
R06.0
ICD-10 Finland
Dyspnoea
5.3
26.3
100
295
Z94.1
ICD-10 Finland
Heart transplant status
152.6
26.2
27
*
R03AK07
ATC
formoterol and budesonide; inhalant
5.9
26.2
87
219
AN1
HP
Coronary angiography
8.4
25.9
61
95
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
8.6
25.9
60
91
L04AA01
ATC
[U] ciclosporin; systemic
23.6
25.3
36
18
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
10.3
25.2
52
64
XX4AW
NOMESCO Finland
NA
146.3
25.2
26
*
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
9.9
24.8
52
66
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
8.5
24.6
57
86
M05BA04
ATC
alendronic acid; oral
10.1
24.1
50
62
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
6.6
24.0
69
142
ZX100
NOMESCO Finland
Oral
32.4
23.9
31
11
XF400
NOMESCO Finland
ECG with 12 standard connections
5.8
23.6
76
181
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
26.4
23.3
32
14
J01MA12
ATC
levofloxacin; systemic
5.4
23.3
83
222
1CX01
NOMESCO Finland
NA
133.7
23.1
24
*
137
Kela drug reimbursment
Uraemia requiring dialysis
50.9
22.9
27
6
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
4.2
22.8
146
689
ZXA00
NOMESCO Finland
Right side
4.6
22.8
102
346
A11CC03
ATC
alfacalcidol; systemic
21.3
22.5
33
18
ZXE20
NOMESCO Finland
More than three and less than five hours
5.5
22.4
76
191
FXD00
NOMESCO Finland
Use of ECHLA without concurrent surgical procedure
+∞
22.2
21
*
AK3
HP
BLTX (both lung transplants)
+∞
22.2
21
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
11.1
22.1
43
47
B05DA
ATC
Isotonic solutions
55.9
21.6
25
5
Z49.2
ICD-10 Finland
Other dialysis
55.9
21.6
25
5
B01AB04
ATC
dalteparin; parenteral
12.5
21.4
39
37
RS230
NOMESCO Finland
NA
66.8
21.3
24
*
Z3229
NOMESCO Finland
Other healthcare associate professional
7.7
21.1
52
85
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.3
20.6
71
179
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
4.9
20.4
79
226
J43.9
ICD-10 Finland
Emphysema, unspecified
63.7
20.3
23
*
N18.8
ICD-10 Finland
Other chronic renal failure
20.2
20.2
30
17
J01FA10
ATC
azithromycin; systemic
4.1
20.0
170
980
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
20.6
19.7
29
16
RD210
NOMESCO Finland
NA
15.3
19.4
32
24
GBB00
NOMESCO Finland
Tracheostomy
38.1
19.3
24
7
N02AX02
ATC
tramadol; systemic, rectal
3.7
19.3
135
651
RS221
NOMESCO Finland
NA
17.1
19.1
30
20
E88.0
ICD-10 Finland
Disorders of plasma-protein metabolism, not elsewhere classified
206.5
18.8
19
*
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
14.2
18.8
32
26
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
6.9
18.3
48
85
R52.0
ICD-10 Finland
Acute pain
17.6
18.0
28
18
B01AA03
ATC
warfarin; systemic
4.9
17.9
65
171
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
6.0
17.9
53
110
TPX10
NOMESCO Finland
Implantation of vascular injection port
15.7
17.9
29
21
Z94.3
ICD-10 Finland
Heart and lungs transplant status
194.7
17.8
18
*
R03AC13
ATC
formoterol; inhalant
13.1
17.7
31
27
R03AK06
ATC
salmeterol and fluticasone; inhalant
5.1
17.5
61
153
TDM10
NOMESCO Finland
Puncture of maxillary antrum
10.6
17.4
34
37
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
68.8
17.0
19
*
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
19.9
16.9
25
14
I27.0
ICD-10 Finland
Primary pulmonary hypertension
+∞
16.9
16
*
E84.0
ICD-10 Finland
Cystic fibrosis with pulmonary manifestations
+∞
16.9
16
*
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
9.8
16.7
34
40
B05DB
ATC
Hypertonic solutions
51.6
16.3
19
*
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
13.2
16.1
28
24
B07.9
ICD-10 Finland
Verruca simplex
11.4
16.0
30
30
J01GB01
ATC
tobramycin; inhalant, parenteral
64.8
16.0
18
*
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
64.8
16.0
18
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
8.0
16.0
37
54
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
4.3
15.9
67
202
Z49.1
ICD-10 Finland
Extracorporeal dialysis
28.7
15.9
21
8
N02AA05
ATC
oxycodone; systemic
5.3
15.9
52
121
RK110
NOMESCO Finland
NA
91.6
15.8
17
*
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
171.4
15.7
16
*
RK320
NOMESCO Finland
NA
41.2
15.6
19
5
B03XA01
ATC
erythropoietin; parenteral
41.2
15.6
19
5
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
25.6
15.4
21
9
A02BC05
ATC
esomeprazole; systemic
3.2
15.3
122
608
XJC02
NOMESCO Finland
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
48.7
15.3
18
*
ZX121
NOMESCO Finland
Central venous catheter
48.7
15.3
18
*
JN4AD
NOMESCO Finland
Body CT examination
6.3
15.2
42
79
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
60.9
15.0
17
*
Z94.4
ICD-10 Finland
Liver transplant status
60.9
15.0
17
*
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
60.9
15.0
17
*
J01CA04
ATC
amoxicillin; systemic
5.1
15.0
204
1512
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
27.3
15.0
20
8
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
27.3
15.0
20
8
R03BB01
ATC
ipratropium bromide; inhalant
23.0
15.0
21
10
304
Kela drug reimbursment
Dornase alfa
+∞
14.7
14
*
R05CB13
ATC
dornase alfa (desoxyribonuclease); inhalant
+∞
14.7
14
*
AP2
HP
Catheterization of the right side of the heart
+∞
14.7
14
*
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
10.2
14.7
29
32
Z01.8
ICD-10 Finland
Other specified special examinations
3.7
14.7
78
286
H02AB04
ATC
methylprednisolone; systemic
4.3
14.6
61
181
A02BC01
ATC
omeprazole; systemic
3.5
14.6
83
321
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
24.2
14.5
20
9
A02BC02
ATC
pantoprazole; systemic
3.2
14.5
164
1029
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
25.8
14.0
19
8
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
36.6
13.7
17
5
H26.3
ICD-10 Finland
Drug-induced cataract
36.6
13.7
17
5
3A064
NOMESCO Finland
NA
+∞
13.7
13
*
FXF00
NOMESCO Finland
Decannulation after ECHLA or ECLA
+∞
13.7
13
*
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
12.6
13.7
24
21
T86.8
ICD-10 Finland
Failure and rejection of other transplanted organs and tissues
148.5
13.6
14
*
J45.9
ICD-10 Finland
Asthma, unspecified
4.0
13.6
61
193
B03XA02
ATC
darbepoetin alfa; parenteral
15.1
13.6
22
16
C10AX09
ATC
ezetimibe; oral
4.5
13.5
51
137
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
6.6
13.4
35
61
WW200
NOMESCO Finland
Immunization
8.4
13.2
29
39
R03DA04
ATC
theophylline; systemic, rectal
10.0
13.1
26
29
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
4.9
13.1
45
109
WX720
NOMESCO Finland
Own respiration
10.7
13.1
25
26
SAA04
NOMESCO Finland
Special inverstigation of mouth
6.6
13.0
34
59
M81.9
ICD-10 Finland
Osteoporosis, unspecified
15.3
13.0
21
15
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
5.2
13.0
42
95
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
10.3
12.9
25
27
SAA03
NOMESCO Finland
Extended examination of mouth
2.9
12.8
122
657
SPAT1325
SPAT
Vaccination
3.0
12.8
96
445
RS220
NOMESCO Finland
NA
18.7
12.8
19
11
TK820
NOMESCO Finland
Peritoneal dialysis
74.1
12.7
14
*
JN4CD
NOMESCO Finland
Very extensive body CT
9.3
12.7
26
31
C02KX01
ATC
bosentan; oral
+∞
12.6
12
*
V03AE02
ATC
sevelamer; oral
+∞
12.6
12
*
FXE00
NOMESCO Finland
Use of ECLA
+∞
12.6
12
*
J01XB01
ATC
colistin; inhalant, parenteral
137.3
12.6
13
*
E84.9
ICD-10 Finland
Cystic fibrosis, unspecified
137.3
12.6
13
*
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
39.9
12.4
15
*
GD1LA
NOMESCO Finland
GD
28.5
12.2
16
6
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
28.5
12.2
16
6
Z49.0
ICD-10 Finland
Preparatory care for dialysis
28.5
12.2
16
6
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
8.1
12.1
27
37
J05AB11
ATC
valaciclovir; oral
4.2
11.8
48
137
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
20.3
11.8
17
9
G04BE03
ATC
sildenafil; oral
20.3
11.8
17
9
UDH02
NOMESCO Finland
Rhinopharyngoscopy
6.0
11.8
33
63
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
3.6
11.8
60
209
A12AA04
ATC
calcium carbonate; oral
14.7
11.7
19
14
348
Kela drug reimbursment
Roflumilast
+∞
11.6
11
*
2770A
ICD-9 Finland
Other and unspecified disorders of metabolism, Cystic fibrosis
+∞
11.6
11
*
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
+∞
11.6
11
*
L01XE31
ATC
[U] nintedanib; oral
126.1
11.5
12
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.6
11.5
41
103
WX002
NOMESCO Finland
Sedation and analgesia
3.3
11.4
68
264
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
6.6
11.3
29
49
N03AX16
ATC
pregabalin; oral
3.1
11.3
75
315
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
8.1
11.3
25
34
TK810
NOMESCO Finland
Hemofiltration
45.7
11.0
13
*
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
45.7
11.0
13
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
6.7
11.0
28
47
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
22.8
10.8
15
7
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.7
10.8
98
500
EBA10
NOMESCO Finland
Surgical removal of tooth
3.7
10.6
49
156
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
6.9
10.5
26
42
J01MA02
ATC
ciprofloxacin; systemic
2.7
10.5
98
507
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
20.0
10.4
15
8
3AC01
NOMESCO Finland
NA
20.0
10.4
15
8
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
20.0
10.4
15
8
B02.9
ICD-10 Finland
Zoster without complication
5.6
10.3
30
60
I50.9
ICD-10 Finland
Heart failure, unspecified
4.7
10.3
35
84
A09AA02
ATC
multienzymes (lipase, protease etc.)
15.5
10.2
16
11
R03BA02
ATC
budesonide; inhalant
3.3
10.1
58
216
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.5
10.0
49
164
D70.82
ICD-10 Finland
Drug-induced neutropenia
21.2
9.9
14
7
J01DB01
ATC
cefalexin; oral
3.2
9.8
194
1500
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
57.5
9.7
11
*
J45.0
ICD-10 Finland
Predominantly allergic asthma
4.4
9.7
36
94
R03AC03
ATC
terbutaline; inhalant
3.5
9.6
48
163
N17.9
ICD-10 Finland
Acute renal failure, unspecified
7.5
9.6
22
32
J01AA02
ATC
doxycycline; systemic
2.8
9.6
181
1348
602
Kela drug reimbursment
Children's severe malnutrition
18.5
9.5
14
8
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
13.1
9.5
16
13
R28
ICPC
Limited function/disability (R)
13.1
9.5
16
13
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
4.0
9.5
39
112
J02AC03
ATC
voriconazole; systemic
31.5
9.5
12
*
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
31.5
9.5
12
*
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
31.5
9.5
12
*
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
4.9
9.5
31
71
J43.1
ICD-10 Finland
Panlobular emphysema
104.2
9.5
10
*
E84.8
ICD-10 Finland
Cystic fibrosis with other manifestations
104.2
9.5
10
*
TQW99
NOMESCO Finland
Other minor procedure on skin
7.9
9.5
21
29
B01AC11
ATC
iloprost; inhalant, parenteral
+∞
9.4
9
*
GX1K5
NOMESCO Finland
Diffusion capacity
+∞
9.4
9
*
RS310
NOMESCO Finland
NA
+∞
9.4
9
*
E84.1
ICD-10 Finland
Cystic fibrosis with intestinal manifestations
+∞
9.4
9
*
SPAT1262
SPAT
Handing over of treatment supplies
3.0
9.3
59
238
M01AH05
ATC
etoricoxib; oral
0.4
9.2
51
976
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
16.5
9.2
14
9
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
38.3
9.1
11
*
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
38.3
9.1
11
*
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
38.3
9.1
11
*
L57.0
ICD-10 Finland
Actinic keratosis
5.0
9.1
29
65
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
25.2
9.0
12
5
K05.30
ICD-10 Finland
Periodontitis complex
3.4
8.9
46
160
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
3.4
8.9
45
154
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
3.4
8.8
45
155
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.5
8.8
31
77
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
52.0
8.7
10
*
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
52.0
8.7
10
*
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
52.0
8.7
10
*
JN3AD
NOMESCO Finland
Abdominal CT examination
4.3
8.7
32
83
6BA02
NOMESCO Finland
NA
17.1
8.7
13
8
V03AE01
ATC
polystyrene sulfonate; oral
17.1
8.7
13
8
J47
ICD-10 Finland
Bronchiectasis
17.1
8.7
13
8
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
17.1
8.7
13
8
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.4
8.6
115
693
J05AB01
ATC
aciclovir; systemic
2.9
8.6
57
233
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
21.0
8.6
12
6
FWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels
28.7
8.6
11
*
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
6.3
8.5
22
38
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.8
8.5
28
65
N18.0
ICD-10 Finland
End-stage renal disease
13.5
8.5
14
11
N17.8
ICD-10 Finland
Other acute renal failure
13.5
8.5
14
11
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
13.5
8.5
14
11
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
93.4
8.5
9
*
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
93.4
8.5
9
*
J84.0
ICD-10 Finland
Alveolar and parietoalveolar conditions
93.4
8.5
9
*
UJF32
NOMESCO Finland
Coloscopy
2.7
8.5
67
306
WZC30
NOMESCO Finland
Teaching
3.2
8.4
47
172
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
4.9
8.4
27
61
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.8
8.4
59
250
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
4.2
8.4
32
86
115
NOMESCO Finland
NA
+∞
8.4
8
*
L04AA05
ATC
[U] tacrolimus; systemic
+∞
8.4
8
*
GX1D5
NOMESCO Finland
Flow volume spirometry
+∞
8.4
8
*
R03DX07
ATC
roflumilast; oral
+∞
8.4
8
*
JD1FN
NOMESCO Finland
Scintigraphy of gastric function
+∞
8.4
8
*
WX721
NOMESCO Finland
Oxygen concentrator therapy
+∞
8.4
8
*
XG460
NOMESCO Finland
Short time oxymetry
15.2
8.3
13
9
J45.1
ICD-10 Finland
Nonallergic asthma
4.3
8.3
30
77
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
12.3
8.2
14
12
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.7
8.2
27
63
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
10.6
8.2
15
15
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
34.7
8.1
10
*
XW000
NOMESCO Finland
Bone marrow biopsy
6.1
8.1
21
37
KA1AE
NOMESCO Finland
Kidney ultrasound examination
8.3
8.0
17
22
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
3.8
8.0
34
101
R99
ICPC
Respiratory disease other
13.7
8.0
13
10
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
13.7
8.0
13
10
ZXA05
NOMESCO Finland
Left side
2.6
7.9
66
310
V03AG01
ATC
sodium cellulose phosphate; systemic
46.6
7.8
9
*
L03AA02
ATC
filgrastim; parenteral
8.5
7.7
16
20
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.4
7.7
81
430
R05CB01
ATC
acetylcysteine; inhalant, oral
12.4
7.7
13
11
K06.19
ICD-10 Finland
Gingival hyperplasia UNS
19.2
7.7
11
6
K06.18
ICD-10 Finland
Another gingival hyperplasia
19.2
7.7
11
6
ZXC50
NOMESCO Finland
Cryotherapy
9.4
7.7
15
17
J01FA06
ATC
roxithromycin; oral
2.3
7.6
95
545
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
26.0
7.6
10
*
XJC00
NOMESCO Finland
Oesophageal manometry
26.0
7.6
10
*
FN1CD
NOMESCO Finland
Very extensive CT of coronary arteries
26.0
7.6
10
*
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
3.7
7.6
33
100
A41.9
ICD-10 Finland
Sepsis, unspecified
6.9
7.6
18
28
WX722
NOMESCO Finland
PEEP
5.3
7.5
22
45
HA1AA
NOMESCO Finland
X-ray mammography
4.6
7.5
25
59
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
14.0
7.5
12
9
I27.8
ICD-10 Finland
Other specified pulmonary heart diseases
82.7
7.5
8
*
XX7LW
NOMESCO Finland
NA
82.7
7.5
8
*
B34.9
ICD-10 Finland
Viral infection, unspecified
7.3
7.4
17
25
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.4
7.4
36
119
N02BE01
ATC
paracetamol; systemic, rectal
2.7
7.4
192
1547
ZX196
NOMESCO Finland
NA
+∞
7.3
7
*
XF614
NOMESCO Finland
Measurement of pulmonary artery pressure
+∞
7.3
7
*
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
8.4
7.2
15
19
J12.8
ICD-10 Finland
Other viral pneumonia
31.1
7.2
9
*
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
20.8
7.2
10
5
EB1WA
NOMESCO Finland
NA
20.8
7.2
10
5
UJC12
NOMESCO Finland
Flexible oesophagoscopy
20.8
7.2
10
5
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
12.6
7.2
12
10
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
12.6
7.2
12
10
J96.0
ICD-10 Finland
Acute respiratory failure
12.6
7.2
12
10
K65.0
ICD-10 Finland
Acute peritonitis
12.6
7.2
12
10
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
7.4
7.1
16
23
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
10.5
7.1
13
13
D64.9
ICD-10 Finland
Anaemia, unspecified
4.1
7.1
27
73
TFP20
NOMESCO Finland
Cardiodefibrillation
4.1
7.1
27
73
R03BA05
ATC
fluticasone; inhalant
2.6
7.0
53
235
J01FF01
ATC
clindamycin; systemic
2.3
7.0
73
383
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
14.4
7.0
11
8
R05CB02
ATC
bromhexine; systemic
14.4
7.0
11
8
ZYC01
NOMESCO Finland
Remote contact by phone
5.0
6.9
21
45
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
9.8
6.9
13
14
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
5.2
6.9
20
41
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.8
6.9
48
201
I20.99
ICD-10 Finland
Angina pectoris, unspecified
4.5
6.8
23
55
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
5.5
6.8
19
37
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
5.5
6.8
19
37
XG467
NOMESCO Finland
Nocturnal CO2 monitoring
41.3
6.8
8
*
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
41.3
6.8
8
*
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
41.3
6.8
8
*
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
41.3
6.8
8
*
RK250
NOMESCO Finland
NA
41.3
6.8
8
*
V03AE03
ATC
lanthanum carbonate; oral
41.3
6.8
8
*
XF622
NOMESCO Finland
Measurement of minute volume of heart
41.3
6.8
8
*
H25.1
ICD-10 Finland
Senile nuclear cataract
3.0
6.8
41
156
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.2
6.7
37
132
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.6
6.7
30
93
A07AA09
ATC
vancomycin; oral
12.8
6.6
11
9
J45.8
ICD-10 Finland
Mixed asthma
9.1
6.6
13
15
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
9.1
6.6
13
15
K03.66
ICD-10 Finland
Tooth plaque
3.7
6.6
28
83
R4130
NOMESCO Finland
Speech therapy
7.2
6.6
15
22
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.1
6.6
112
725
K29.7
ICD-10 Finland
Gastritis, unspecified
6.5
6.6
16
26
R04.2
ICD-10 Finland
Haemoptysis
6.5
6.6
16
26
N05CF01
ATC
zopiclone; oral
2.3
6.5
72
383
C01AA05
ATC
digoxin; systemic
5.2
6.5
19
39
GDA10
NOMESCO Finland
Biopsy of lung
71.8
6.5
7
*
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
14.9
6.5
10
7
C02CA01
ATC
prazosin; oral
14.9
6.5
10
7
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
14.9
6.5
10
7
XFE00
NOMESCO Finland
Epicardial ultrasonography
8.5
6.4
13
16
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.1
6.4
99
615
H65.3
ICD-10 Finland
Chronic mucoid otitis media
9.7
6.4
12
13
N19
ICD-10 Finland
Unspecified kidney failure
7.4
6.3
14
20
334
Kela drug reimbursment
Treprostinil
+∞
6.3
6
*
3A149
NOMESCO Finland
NA
+∞
6.3
6
*
Y83.0
ICD-10 Finland
Surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
+∞
6.3
6
*
B01AC21
ATC
treprostinil; parenteral
+∞
6.3
6
*
J93.0
ICD-10 Finland
Spontaneous tension pneumothorax
+∞
6.3
6
*
GCA18
NOMESCO Finland
Bronchoscopic dilatation of bronchus
+∞
6.3
6
*
C02KX04
ATC
macitentan; oral
+∞
6.3
6
*
JC2FN
NOMESCO Finland
Scintigraphy of oesophageal function
+∞
6.3
6
*
742
NOMESCO Finland
NA
+∞
6.3
6
*
KAC00
NOMESCO Finland
Nephrectomy
+∞
6.3
6
*
I50.0
ICD-10 Finland
Congestive heart failure
6.1
6.3
16
28
R03AC12
ATC
salmeterol; inhalant
6.1
6.3
16
28
XX2XT
NOMESCO Finland
Other injection with other radiological guidance
27.5
6.3
8
*
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
27.5
6.3
8
*
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
5.2
6.2
18
37
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.6
6.2
47
207
F43.29
ICD-10 Finland
Adaptation disorder UNS
7.0
6.1
14
21
ZY000
NOMESCO Finland
Hospital inpatient
9.0
6.1
12
14
ZY010
NOMESCO Finland
Hospital outpatient
3.8
6.0
24
68
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
196
78
111.11
311.48
6.3
3.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
191
24
329.74
307.65
5.3
1.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
193
26
317.91
307.65
5.1
1.7
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
215
64
228.25
307.65
40.6
8.2
iu/ml
192.4
474.5
0.53
104
13
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
180
35
179.28
307.65
4.5
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
187
46
156.51
307.65
4.9
1.6
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
212
50
267.45
307.65
12.7
4.6
u/ml
960.1
4920.0
—
16
5
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
184
35
194.20
307.65
4.4
1.5
—
—
—
0
0
(44790048)
189
34
221.99
307.65
5.6
1.6
—
—
—
0
0
(44790047)
189
34
221.99
307.65
5.6
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
192
48
166.92
307.65
5.5
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
195
60
142.19
307.65
5.8
1.8
—
—
—
0
0
(44790049)
189
34
221.99
307.65
5.6
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
196
59
148.04
307.65
5.8
1.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
185
43
160.82
307.65
5.1
1.9
—
—
—
0
0
(44806118)
189
34
221.99
307.65
5.6
1.6
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
234
187
170.99
282.32
38.1
10.9
mmol/l
10.2
8.7
1.84
234
180
(3003458) Phosphate [Moles/volume] in Serum or Plasma
232
272
100.47
221.48
20.4
8.7
mmol/l
1.1
1.1
0.71
232
256
(3023419) Bacteria identified in Sputum by Culture
122
32
73.24
210.40
4.5
2.7
—
—
—
0
0
(4010399)
177
147
38.45
200.24
4.5
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
209
243
46.42
196.38
7.1
1.9
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
210
248
46.72
195.38
34.6
8.5
mmol/l
105.2
103.7
3.74
210
241
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
208
246
44.52
192.96
7.2
2.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
164
8
587.69
186.52
4.3
1.4
ug/l
35.1
71.1
—
164
8
(3024471) HLA-A [Type]
93
10
147.15
184.71
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
93
10
147.15
184.71
1.0
1.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
230
356
66.27
178.32
38.7
4.3
mmol/l
0.8
0.8
5.20
230
336
(3000494) Fungus identified in Specimen by Culture
206
270
37.98
177.09
8.9
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
123
63
37.32
170.42
1.6
1.5
—
—
—
0
0
(3000492) Spirometry study
187
222
30.11
169.68
6.7
1.4
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
129
78
32.97
166.62
7.7
2.3
ug/l
394.4
291.9
0.52
129
72
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
217
337
41.15
165.30
7.4
2.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
97
26
60.18
164.28
1.1
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
98
28
56.78
163.31
3.7
1.9
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
148
9
395.98
162.68
4.3
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
98
29
54.80
161.76
1.1
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
100
32
51.28
161.58
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
100
32
51.28
161.58
2.3
2.4
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
117
60
35.65
161.45
1.5
1.5
u/ml
103.4
84.9
—
13
10
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
118
66
32.85
156.89
6.6
2.9
u/ml
0.3
0.4
1.29
65
40
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
91
23
61.50
155.91
5.4
3.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
98
34
46.65
154.34
3.7
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
206
324
30.89
153.36
7.4
2.0
—
—
—
0
0
(4306422)
98
35
45.29
152.92
1.3
1.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
115
65
31.81
151.90
1.2
1.5
u/ml
412.9
214.7
4.14
88
35
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
207
335
30.54
150.63
9.5
2.8
e6/l
0.8
2.0
1.79
179
187
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
114
68
29.88
146.80
1.2
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
96
42
36.39
139.41
3.2
1.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
91
38
37.00
134.07
1.2
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
91
39
36.04
132.80
1.3
1.3
u/ml
4.0
5.6
0.31
43
18
(3018677) aPTT in Platelet poor plasma by Coagulation assay
191
326
21.33
130.25
8.0
2.6
s
29.7
29.5
0.16
191
318
(3048929) Epstein Barr virus Ab [Presence] in Serum
117
93
22.69
129.98
1.3
1.5
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
89
39
34.81
128.65
1.2
1.3
u/ml
2.9
7.3
0.33
27
12
(3042733) HLA Ab [Presence] in Serum
118
9
244.96
123.16
4.3
4.9
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
137
160
17.65
120.33
2.8
2.5
ug/l
35.8
9.2
12.69
137
140
(3018418) pH of Serum or Plasma
232
571
41.46
117.38
19.5
4.6
ph
7.4
7.4
1.72
46
112
(3033658) Prothrombin time (PT) actual/Normal
222
527
28.80
114.75
19.6
4.4
%
100.3
91.4
5.23
222
521
(3026782) Osmolality of Urine
197
402
19.13
114.48
10.6
2.7
mosm/kgh2o
548.3
585.9
1.50
191
345
(36304419) Bacteria [Presence] in Urine
227
571
32.12
111.22
15.8
2.9
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
203
457
19.00
107.68
4.1
1.5
g/l
2.1
2.5
2.21
194
284
(3030467) Casts [#/volume] in Urine by Automated count
227
591
30.71
107.09
16.1
3.0
e6/l
0.1
0.4
2.09
215
447
(40758558) Short blood count panel - Blood
216
541
22.46
104.32
30.3
7.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
160
278
14.12
103.56
5.3
2.7
%
18.9
23.5
3.18
148
242
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
65
21
41.42
102.75
2.4
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
180
367
14.80
102.31
9.4
2.7
e6/l
0.2
1.0
5.05
160
218
(3002582) Erythrocytes [#/volume] in Urine
228
646
28.60
97.83
18.0
3.1
e6/l
7.7
144.6
0.79
219
506
(3006184) Hemoglobin [Mass/volume] in Capillary blood
73
44
22.98
91.16
2.6
2.5
g/l
120.9
136.2
2.04
17
35
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
107
128
13.83
89.98
7.8
3.5
ng/l
142.8
180.3
0.47
102
110
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
216
617
18.93
89.65
16.5
2.2
u/l
87.9
215.0
4.59
216
584
(3011397) Hemoglobin [Presence] in Urine by Test strip
191
475
13.64
89.21
6.7
3.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
67
37
24.34
86.83
2.3
1.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
234
764
31.46
85.44
19.5
3.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
232
753
28.49
84.96
44.8
6.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
110
149
12.36
84.10
2.7
1.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
229
738
24.99
84.04
22.3
3.5
e6/l
25.0
108.7
0.83
220
537
(3021879) Hepatitis B virus core Ab [Presence] in Serum
112
162
11.68
81.20
1.6
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
198
559
13.04
80.57
10.4
4.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
219
728
16.75
75.40
17.8
3.8
u/l
25.5
33.9
6.65
219
693
(3000991) Gas panel - Venous blood
113
184
10.35
73.83
42.7
10.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
123
229
9.57
71.42
37.8
8.7
mmol/l
1.6
1.2
0.54
112
188
(3012516) Albumin [Mass/volume] in Urine
194
595
10.95
70.49
5.0
3.5
mg/l
73.4
170.6
0.42
160
389
(3019060) Gas panel - Arterial blood
96
136
10.81
69.81
6.3
5.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
171
469
9.30
68.76
6.3
2.0
mg/l
1.5
1.2
0.58
150
362
(3017181) Myelocytes/100 leukocytes in Blood
111
192
9.57
68.37
12.6
5.3
%
0.6
0.8
0.37
63
65
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
241
967
38.46
67.38
49.5
8.4
mmol/l
1.2
1.2
2.58
234
824
(3020682) Albumin/Creatinine [Ratio] in Urine
195
629
10.41
66.34
5.3
4.2
mg/mmol
12.3
10.1
0.22
160
402
(3034426) Prothrombin time (PT)
41
12
40.64
65.69
1.0
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
42
14
35.83
64.82
1.2
1.1
—
—
—
0
0
(4268621)
52
32
20.23
63.40
2.2
2.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
145
364
8.06
62.39
5.8
3.9
ng/l
3570.9
436.0
4.62
138
276
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
81
109
10.50
60.69
8.8
7.8
mmol/l
24.1
24.1
0.02
70
101
(3002032) Base excess in Venous blood by calculation
104
192
8.54
59.64
10.1
6.6
mmol/l
1.5
1.8
0.26
87
161
(3017143) Hepatitis C virus Ab [Presence] in Serum
123
272
7.91
59.52
2.0
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
121
265
7.89
59.04
2.8
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
53
42
15.73
56.41
3.2
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
51
38
16.59
56.17
3.2
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
163
500
7.45
55.80
5.2
2.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
231
1005
17.30
55.01
48.2
9.9
e9/l
0.0
0.0
0.83
211
827
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
127
312
7.22
54.66
2.0
1.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
154
455
7.17
54.60
3.7
2.1
mg/l
3.3
3.2
0.25
148
393
(3002179) Metamyelocytes/100 leukocytes in Blood
93
176
7.81
51.39
11.9
5.2
%
0.6
0.3
1.88
42
48
(3015736) pH of Urine
200
791
8.52
50.79
8.0
3.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
201
821
8.27
48.52
18.6
8.1
inr
1.2
1.1
0.78
56
257
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
74
116
8.63
48.22
54.3
9.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
45
36
15.01
47.35
1.5
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
45
36
15.01
47.35
1.5
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
32
12
30.42
47.15
1.6
1.4
e6/l
2310.4
1300.6
—
23
7
(3044640) Blood type and Crossmatch panel - Blood
178
668
6.72
46.57
5.7
2.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
198
821
7.69
46.20
5.0
2.0
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
87
170
7.30
46.19
12.9
5.6
%
0.0
0.0
0.80
48
51
(3028308) Erythrocytes [#/volume] in Pleural fluid
30
10
33.94
45.84
1.6
1.5
e6/l
145048.1
33838.0
—
21
5
(3045788) Cell count panel - Pleural fluid
30
10
33.94
45.84
1.5
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
130
383
5.97
44.44
2.0
1.9
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
50
9
68.88
44.35
1.1
1.8
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
86
174
7.00
43.94
13.7
5.6
%
0.2
0.2
0.00
57
57
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
71
119
7.93
43.32
2.3
1.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
30
12
28.26
43.14
1.5
1.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
78
146
7.30
42.92
8.0
5.2
ng/l
115.4
86.0
1.69
69
133
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
113
306
5.90
42.17
1.4
1.9
%
1.6
1.5
0.19
102
274
(3027945) Reticulocytes/100 erythrocytes in Blood
98
235
6.20
41.79
7.1
3.3
%
1.8
1.8
0.04
98
217
(3052851) Hemolysis interference index of Serum or Plasma
52
63
10.15
41.40
5.5
3.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
50
60
10.16
40.04
1.6
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
112
317
5.57
39.34
1.9
1.4
titre
398.8
409.7
0.03
34
66
(3035350) Ketones [Presence] in Urine by Test strip
212
1022
7.91
39.20
11.0
3.4
estimate
0.0
0.0
0.00
51
206
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
32
19
19.16
39.10
2.7
3.4
%
119.5
97.3
1.34
32
19
(3051651) Icteric interference index of Serum or Plasma
32
19
19.16
39.10
6.5
3.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
46
51
10.82
39.00
1.6
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
212
1025
7.88
38.97
15.9
4.6
estimate
0.0
0.0
0.00
54
213
(3009261) Glucose [Presence] in Urine by Test strip
213
1039
7.94
38.61
10.9
3.4
estimate
0.0
0.0
0.00
54
205
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
100
261
5.71
38.45
4.6
3.8
umol/l
5.9
10.0
1.51
90
234
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
37
30
14.29
38.38
1.3
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
39
36
12.64
37.36
1.3
1.1
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
238
1314
16.66
37.15
23.3
3.8
e6/l
1.9
175.2
0.56
11
21
(3026008) Bacteria identified in Urine by Culture
142
510
5.11
36.88
5.3
2.7
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
84
194
6.00
36.84
2.7
2.7
u/l
39.7
32.2
0.91
78
162
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
26
11
26.25
36.48
1.5
1.2
u/l
316.4
323.5
0.01
26
11
(3051611) Lipemic interference index of Serum or Plasma
33
24
15.68
36.33
6.9
3.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
49
65
9.12
36.17
1.1
1.5
miu/ml
190.2
292.3
—
5
28
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
53
79
8.24
35.49
10.5
8.9
mg/l
2.0
1.4
4.21
53
74
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
25
11
25.13
34.52
10.6
2.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
78
183
5.73
33.33
3.3
3.1
e9/l
65.9
73.4
0.88
53
136
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
110
352
4.78
32.30
1.5
1.3
iu/ml
19.3
29.6
0.67
29
122
(3037467) Urinalysis macro (dipstick) panel - Urine
239
1426
15.14
31.36
23.0
3.9
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
52
87
7.28
31.24
2.1
2.3
g/l
1.6
1.5
0.29
47
76
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
190
984
4.83
27.82
9.6
4.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
23
14
17.98
27.50
1.6
1.9
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
65
153
5.38
27.27
1.6
2.9
g/l
61.2
66.9
4.74
60
145
(3008536) Aspergillus sp Ab [Presence] in Serum
32
8
45.49
26.54
1.7
1.8
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
30
31
10.86
26.41
10.7
2.3
—
—
—
0
0
(4035726)
73
207
4.56
24.23
1.9
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
29
7
46.61
24.19
1.7
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
31
38
9.17
24.04
6.9
3.8
%
56.5
57.4
0.14
31
38
(3019832) Treponema pallidum Ab [Presence] in Serum
64
165
4.86
23.91
1.2
1.7
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
27
5
60.19
23.57
1.1
1.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
30
37
9.07
23.13
6.2
3.1
e9/l
4.0
4.3
0.31
30
37
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
27
6
50.17
22.86
1.1
1.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
21
16
14.23
22.23
2.6
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
20
14
15.44
22.16
2.6
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
120
511
3.58
21.93
24.3
4.8
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
20
15
14.40
21.33
1.9
3.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
52
124
5.03
21.18
9.9
2.6
e6/l
0.2
0.1
0.44
52
119
(3025941) Bacteria identified in Stool by Culture
50
116
5.13
21.02
1.6
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
27
33
9.05
20.91
5.1
3.0
—
—
—
0
0
(3012501) Base excess in Blood by calculation
30
44
7.61
19.99
13.2
3.6
mmol/l
2.9
2.3
0.45
20
28
(3013290) Carbon dioxide [Partial pressure] in Blood
30
44
7.61
19.99
13.2
3.6
kpa
5.3
5.0
0.87
30
44
(3027315) Oxygen [Partial pressure] in Blood
30
44
7.61
19.99
13.2
3.6
kpa
8.6
8.7
0.12
30
44
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
18
13
14.84
19.55
2.7
1.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
18
13
14.84
19.55
2.7
1.7
—
—
—
0
0
(3044889) 12 lead EKG panel
222
1481
5.32
18.96
22.5
3.7
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
35
65
6.10
18.66
13.8
3.8
kpa
8.9
8.9
0.02
35
60
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
57
162
4.26
18.50
12.3
4.2
mmol/l
1.8
1.7
0.04
46
122
(3009343) pH of Capillary blood
58
169
4.16
18.19
13.0
4.1
ph
7.4
7.4
0.84
12
17
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
18
15
12.85
17.99
1.7
3.4
%
10.8
14.7
—
10
9
(3003694) ABO and Rh group [Type] in Blood
128
622
3.16
17.97
1.9
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
18
16
12.04
17.29
1.4
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
78
290
3.45
17.02
1.3
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
27
42
7.08
17.02
12.1
3.9
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
57
172
3.99
16.97
4.0
2.7
ml/min/173m2
37.4
64.6
10.60
37
76
(3020891) Body temperature
36
75
5.44
16.96
12.3
5.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
68
233
3.63
16.82
2.9
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
33
64
5.79
16.78
1.5
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
54
159
4.05
16.61
12.3
4.6
mmol/l
1.2
1.2
0.14
54
143
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
21
25
9.08
16.50
1.9
1.9
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
21
25
9.08
16.50
1.9
1.9
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
21
25
9.08
16.50
1.9
1.9
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
33
66
5.61
16.23
1.5
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
33
66
5.61
16.23
1.5
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
90
376
3.17
16.10
1.8
1.6
pmol/l
506.0
446.0
0.98
81
318
(3019230) Fractional oxyhemoglobin in Venous blood
25
38
7.20
16.07
6.8
6.1
%
63.8
67.6
0.32
25
38
(3008757) Leukocyte morphology finding [Identifier] in Blood
23
32
7.81
15.95
11.3
4.1
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
21
8
28.46
15.87
1.0
1.0
%
101.0
123.0
—
21
8
(3024891) Influenza virus A+B Ag [Presence] in Specimen
31
60
5.75
15.77
1.4
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
45
120
4.35
15.76
2.0
1.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
221
1551
4.55
15.63
5.3
3.7
pmol/l
14.0
14.8
5.27
215
1406
(40767503) Oxygen content in Capillary blood by calculation
24
39
6.70
14.48
5.5
2.4
%
16.0
17.7
0.95
16
19
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
19
8
25.54
14.01
1.1
1.1
u/l
9.3
13.8
—
19
8
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
14
12
12.30
13.64
2.1
2.8
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
22
36
6.60
13.16
8.7
4.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
138
799
2.62
12.59
5.7
3.6
ng/l
67.1
37.2
1.75
127
549
(3028433) Virus identified in Specimen by Culture
13
12
11.37
12.05
1.3
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
15
5
31.74
11.78
1.5
7.6
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
64
4.80
11.77
1.3
2.0
g/l
3.3
3.1
0.62
21
53
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
16
7
24.28
11.72
4.1
2.6
umol/l
24.9
27.3
—
16
7
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
21
37
6.10
11.68
1.3
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
40
121
3.74
11.67
1.5
2.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
16
8
21.24
11.28
6.7
6.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
68
4.51
10.93
1.3
2.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
68
4.51
10.93
1.3
2.0
g/l
3.6
3.8
0.37
21
52
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
68
4.51
10.93
1.3
2.0
g/l
7.9
7.3
0.92
21
56
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
15
7
22.67
10.81
6.5
6.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
22
44
5.38
10.73
7.3
6.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
28
69
4.44
10.73
1.4
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
14
17
8.66
10.71
1.5
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
14
6
24.58
10.36
2.7
6.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
40
132
3.42
10.20
12.9
4.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
69
311
2.68
10.17
1.7
1.6
nmol/l
1033.9
1208.1
0.93
61
244
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
13
5
27.28
9.91
1.2
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
102
561
2.38
9.78
12.3
3.5
estimate
0.0
0.0
0.50
51
205
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
24
58
4.47
9.41
1.4
1.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
51
205
2.87
9.29
4.4
3.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
12
5
25.08
8.99
1.0
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
19
39
5.19
8.99
1.4
1.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
241
2016
5.91
8.85
97.4
14.7
%
36.0
40.8
35.00
226
1531
(3043409) Potassium [Moles/volume] in Arterial blood
24
61
4.24
8.83
11.8
4.2
mmol/l
4.0
3.8
1.43
19
55
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
22
53
4.45
8.65
1.4
2.0
g/l
0.1
0.1
0.06
22
53
(3038071) Oxygen [Partial pressure] in Mixed venous blood
12
6
20.90
8.55
2.8
6.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
13
19
7.16
8.52
1.4
9.5
%
9.9
11.8
1.19
13
19
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
20
46
4.64
8.31
1.3
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
34
116
3.23
8.18
1.5
1.3
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
12
7
17.90
8.15
1.5
1.1
u/l
12.6
19.6
—
12
7
(3000093) Morphology [Interpretation] in Blood Narrative
15
27
5.85
8.12
1.3
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
12
17
7.36
8.06
1.6
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
116
716
2.15
8.05
2.0
1.9
pmol/l
95.9
95.2
0.05
64
371
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
20
48
4.44
7.89
1.4
1.8
g/l
0.0
0.0
0.00
20
48
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
20
48
4.44
7.89
1.4
1.8
g/l
0.0
0.0
0.00
20
48
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
192
1451
2.38
7.88
4.7
3.0
—
—
—
0
0
(4062490)
15
28
5.63
7.83
1.1
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
125
812
2.07
7.41
11.2
3.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
23
67
3.68
7.03
2.3
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
43
848
0.41
6.96
3.0
2.8
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
10
14
7.40
6.74
2.4
1.4
e9/l
0.1
0.2
—
10
14
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
227
1912
2.96
6.42
8.2
4.3
mu/l
1.9
1.9
0.27
222
1753
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
18
47
4.05
6.38
1.5
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
9
5
18.59
6.31
1.3
1.0
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
6
0
+∞
6.27
1.3
0.0
nmol/l
10.5
—
—
6
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
19
53
3.80
6.17
1.3
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
10
16
6.47
6.00
1.7
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
94
589
1.95
5.84
10.6
2.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
233
2014
3.19
5.80
71.5
12.4
ml/min/173m2
66.0
84.7
17.00
224
1659
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
22
71
3.30
5.77
2.8
1.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
47
230
2.28
5.58
40.1
18.3
inr
2.0
1.4
—
7
27
(21494814) CD8 cells/100 lymphocytes in Specimen
8
5
16.45
5.44
2.4
1.4
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
8
5
16.45
5.44
2.4
1.4
%
6.3
7.0
—
8
5
(40761535) Cells panel - Urine sediment
38
171
2.44
5.44
8.2
3.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
77
461
1.97
5.40
10.2
3.5
kg/l
1.0
1.0
—
5
66
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
15
39
4.03
5.34
1.1
2.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
22
76
3.08
5.18
3.3
1.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
21
71
3.14
5.12
1.1
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
15
41
3.83
5.00
1.7
2.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
23
84
2.91
4.93
6.5
5.9
g/l
0.4
0.3
0.29
16
46
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
24
90
2.84
4.91
1.6
2.5
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
29
121
2.58
4.85
12.8
4.8
mmol/l
24.4
25.0
0.53
29
114
(3024980) IgG subclass 4 [Mass/volume] in Serum
16
47
3.57
4.83
1.3
1.8
g/l
0.4
0.9
0.93
11
39
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
7
5
14.34
4.60
1.7
1.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
17
54
3.30
4.58
3.0
3.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
234
0.24
4.32
1.5
1.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
109
0.00
4.31
0.0
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
10
8.22
4.09
2.3
2.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
10
8.22
4.09
2.3
2.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
10
8.22
4.09
2.3
2.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
10
8.22
4.09
2.3
2.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
37
187
2.15
4.04
14.0
3.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
9
15
6.18
3.85
1.1
2.9
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
9
15
6.18
3.85
1.1
2.9
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
7
236
0.28
3.83
1.4
1.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
8
8.96
3.79
2.0
3.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
8
8.96
3.79
2.0
3.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
8
8.96
3.79
2.0
3.0
—
—
—
0
0
(3002256) Pathology report gross observation
48
276
1.91
3.69
1.4
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
9
17
5.45
3.54
1.6
1.6
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
9
18
5.14
3.40
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
14
5.86
3.36
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
14
5.86
3.36
1.0
1.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
77
525
1.67
3.32
1.5
2.8
ug/l
0.5
0.7
3.55
54
337
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
15
5.47
3.21
1.0
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
17
67
2.65
3.20
1.0
1.5
ug/g
257.1
289.0
—
8
41
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
23
106
2.29
3.14
2.0
2.3
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
8
16
5.13
3.07
1.4
1.8
umol/l
12.1
11.1
—
8
16
(3044242) Glucose [Moles/volume] in Arterial blood
7
12
5.96
3.04
1.1
6.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
8
17
4.82
2.94
1.4
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
30
3.43
2.94
1.3
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
214
0.35
2.83
1.1
2.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
10
31
3.32
2.80
1.5
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
9
23
4.02
2.80
1.2
1.1
u/ml
—
—
—
0
0
(21494434) Karyotype in Bone marrow
9
24
3.85
2.70
1.8
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
38
2.98
2.61
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
11
38
2.98
2.61
1.5
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
11
38
2.98
2.61
1.5
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
7
15
4.77
2.61
2.7
1.3
u/ml
0.9
0.7
—
7
8
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
7
15
4.77
2.61
1.7
1.9
g/l
0.9
1.0
—
7
15
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
7
7.26
2.56
1.2
1.0
miu/ml
1609.6
1555.6
—
5
7
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
115
905
1.50
2.55
3.2
4.5
ug/l
1.4
2.0
2.27
97
820
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
21
3.90
2.48
1.1
1.4
—
—
—
0
0
(3016750) Collection duration of Urine
6
12
5.09
2.41
4.7
2.5
min
559.3
517.4
—
6
7
(3035637) Corticotropin [Mass/volume] in Plasma
9
28
3.29
2.33
1.8
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
13
4.70
2.28
1.5
1.5
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
13
4.70
2.28
1.3
4.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
13
4.70
2.28
1.5
1.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
13
4.70
2.28
1.3
4.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
94
723
1.48
2.28
2.9
4.1
%
25.8
21.2
1.62
28
347
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
9
5.64
2.22
1.0
1.3
u/l
287.6
210.8
—
5
9
(4015189)
5
9
5.64
2.22
1.8
3.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
26
145
1.88
2.20
2.8
2.3
e9/l
3.4
4.1
1.06
19
117
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
10
5.08
2.08
1.4
1.0
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
6
15
4.07
2.05
4.0
2.5
ml
804.2
645.8
—
6
8
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
11
239
0.44
2.02
1.3
2.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
21
3.40
1.98
1.0
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
21
3.40
1.98
2.1
3.3
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
16
78
2.12
1.95
1.7
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
33
206
1.69
1.95
2.5
4.7
ug/l
19.7
42.1
0.36
25
164
(3051593) INR in Capillary blood by Coagulation assay
5
11
4.61
1.95
1.2
7.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
12
4.23
1.83
3.2
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
12
4.23
1.83
1.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
12
4.23
1.83
1.4
6.7
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
8
29
2.81
1.80
1.3
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
36
2.55
1.75
1.0
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
13
3.90
1.72
1.2
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
19
3.21
1.67
1.7
1.4
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
25
2.85
1.66
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
25
2.85
1.66
1.1
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
25
2.85
1.66
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
26
2.74
1.59
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
26
2.74
1.59
1.1
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
26
2.74
1.59
1.1
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
20
3.05
1.59
2.5
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
239
2281
2.00
1.56
48.3
13.0
—
—
—
0
0
(3004451) EKG impression Narrative
5
15
3.38
1.53
1.2
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
9
37
2.48
1.49
4.4
1.5
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
7
28
2.54
1.46
1.1
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
13
67
1.99
1.41
4.2
2.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
41
2.24
1.38
1.1
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
41
0.00
1.32
0.0
1.0
—
—
—
0
0
(3013512) EKG study
75
607
1.34
1.26
7.3
3.7
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
25
2.43
1.25
1.0
1.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
6
25
2.43
1.25
2.5
1.7
ug/l
11.3
18.7
—
6
25
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
12
64
1.92
1.20
1.4
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
21
2.41
1.09
1.2
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
123
0.48
1.08
1.2
1.0
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
9
49
1.87
0.99
2.2
2.2
e6/l
1217.2
2370.3
—
9
40
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
9
49
1.87
0.99
2.2
2.0
e6/l
6.4
10.1
—
9
39
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
29
0.00
0.98
0.0
1.3
—
61.7
—
0
8
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
29
0.00
0.98
0.0
1.1
—
3.2
—
0
13
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
10
54
1.89
0.98
1.1
2.1
u/l
1.4
3915.9
—
5
17
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
31
0.00
0.97
0.0
1.2
—
8.5
—
0
18
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
31
0.00
0.97
0.0
1.1
—
0.6
—
0
11
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
32
0.00
0.95
0.0
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
21
143
1.51
0.93
1.2
1.3
—
35.8
—
0
8
(3048689) Calprotectin [Mass/mass] in Stool
36
273
1.37
0.92
2.0
2.6
ug/g
198.7
110.0
0.71
31
223
(3022145) Colonoscopy Study observation
33
247
1.39
0.91
1.6
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
29
2.09
0.90
2.3
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
14
88
1.63
0.86
4.1
1.6
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
31
1.96
0.85
1.3
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
25
0.00
0.79
0.0
1.6
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
25
0.00
0.79
0.0
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
26
0.00
0.79
0.0
1.7
—
—
—
0
0
(3019225) pH of Specimen
27
201
1.38
0.78
19.2
4.9
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
27
0.00
0.78
0.0
1.1
—
10.0
—
0
14
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
22
158
1.43
0.77
2.3
2.5
—
19.7
—
0
8
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
59
496
1.25
0.74
1.4
1.3
u/ml
0.4
1.3
1.43
17
135
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
58
1.57
0.70
1.7
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
7
41
1.73
0.70
2.3
2.3
—
—
—
0
0
(1002224) Polysomnography panel
7
120
0.57
0.69
1.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
27
1.87
0.69
1.0
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
48
400
1.25
0.65
1.5
1.6
—
—
—
0
0
(4024509)
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
54
1.50
0.58
1.1
1.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
6
36
1.68
0.57
1.0
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
45
1.57
0.49
1.3
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
93
0.64
0.43
1.0
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
70
1.45
0.42
1.5
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
33
1.53
0.41
2.0
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(4027681)
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.0
—
526.9
—
0
9
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
16
0.00
0.41
0.0
1.0
—
36.2
—
0
9
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.0
—
242.0
—
0
9
(3010144) Erythrocytes [#/volume] in Synovial fluid
0
17
0.00
0.41
0.0
1.2
—
13872.2
—
0
12
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
0
18
0.00
0.40
0.0
1.3
—
59.3
—
0
13
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
35
1.44
0.39
2.4
1.6
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
15.2
—
1325.8
—
0
19
(4034850)
9
70
1.30
0.37
15.1
12.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
11
81
1.37
0.37
1.0
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
11
82
1.36
0.34
1.0
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
89
0.67
0.33
1.3
1.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
11
83
1.34
0.32
1.0
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
11
83
1.34
0.32
1.0
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
55
1.28
0.30
4.6
3.9
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
62
1.30
0.28
1.0
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
16
132
1.23
0.26
4.4
2.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
5
74
0.67
0.26
1.0
1.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
9
77
1.18
0.24
1.0
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
28
249
1.14
0.22
1.4
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
11
0.00
0.21
0.0
2.4
—
5.7
—
0
11
(3006462) Nitrate [Presence] in Urine
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
105
0.75
0.21
1.4
1.9
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(4211845)
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
9.5
—
0
12
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
12
0.00
0.21
0.0
1.1
—
7.8
—
0
12
(3035933) Granulocytes/100 leukocytes in Blood
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
10.8
—
0.6
—
0
14
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
20
227
0.87
0.19
1.1
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
38
350
1.10
0.17
1.3
1.3
u/ml
24.7
9.2
0.38
16
146
(36660697) Celiac disease serology panel - Serum
21
187
1.13
0.16
1.3
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
24
265
0.90
0.15
17.3
7.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
12
105
1.15
0.11
8.0
3.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
44
1.14
0.10
3.6
1.7
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
7
64
1.10
0.08
1.4
1.5
mu/l
290.3
353.4
—
7
59
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
81
0.86
0.07
1.4
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
11
112
0.98
0.00
1.2
1.3
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
6.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
61
0.98
0.00
1.2
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
6.7
—
7.6
—
0
9
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
89.1
—
0
7
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
26.3
—
0
5
(4133840)
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
1.9
—
0
5
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
49
1.02
0.00
1.6
1.2
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
21.8
—
0
5
(3011436) Histone Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
5
56
0.89
0.00
1.2
1.6
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
6
0.00
0.00
0.0
1.8
—
154.3
—
0
6
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
17.3
—
0
7
(3013166) Neutrophils/100 leukocytes in Synovial fluid
0
6
0.00
0.00
0.0
1.2
—
48.3
—
0
6
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.1
—
1.6
—
0
7
Mortality – FinRegistry
↥Association
Association between endpoint LUNG_TRANSPLANTATION and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| LUNG_TRANSPLANTATION | 7.063 [4.68, 10.65] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.283 |
During the follow-up period (1.1.1998 — 31.12.2019), 73 out of 232 females with LUNG_TRANSPLANTATION died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| LUNG_TRANSPLANTATION | 5.555 [3.44, 8.97] | < 0.001 |
| Birth year | 0.984 [0.97, 0.99] | 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 119 out of 318 males with LUNG_TRANSPLANTATION died.
Mortality risk
Mortality risk for people of age
years, who have LUNG_TRANSPLANTATION.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.661% | 1.124% |
| 5 | 4.172% | 5.833% |
| 10 | 10.491% | 13.793% |
| 15 | 18.406% | 24.477% |
| 20 | 29.987% | 38.464% |
Relationships between endpoints
↥Index endpoint: LUNG_TRANSPLANTATION – Lung transplantation
GWS hits: 4
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data